TickerFactsScreenerDevelopers

Vanda Pharmaceuticals Inc. (VNDA) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2011: $275.0K2012: $2.02M2013: $176.0K2014: $769.0K2015: $2.53M2016: $1.41M2017: $1.66M2018: $368.0K2019: $1.02M2020: $1.79M2021: $552.0K2022: $679.0K2023: $383.0K2024: $490.0K2025: $998.0K$998.0K
2011Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$998.0K+103.7%
2024$490.0K+27.9%
2023$383.0K-43.6%
2022$679.0K+23.0%
2021$552.0K-69.2%
2020$1.79M+76.2%
2019$1.02M+176.9%
2018$368.0K-77.9%
2017$1.66M+18.3%
2016$1.41M-44.3%
2015$2.53M+228.6%
2014$769.0K+336.9%
2013$176.0K-91.3%
2012$2.02M+633.5%
2011$275.0K—